Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial

• Status: Terminated
• Trial end date: 2016-06-16
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to determine whether bivalirudin is non-inferior to unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kaiser Permanente
• Treatments: Bivalirudin; Calcium heparin; Heparin; Hirudins

Criteria

Inclusion Criteria:

1. Undergoing PCI for stable angina, unstable angina, or non-ST segment elevation myocardial infarction.

2. Age 18 years or older.

Exclusion Criteria:

1. Inability to obtain consent

2. Emergency cardiac catheterization for ST-segment elevation myocardial infarction.